96 related articles for article (PubMed ID: 35694691)
1. Synthesis and pharmacological evaluation of novel N-aryl-cinnamoyl-hydrazone hybrids designed as neuroprotective agents for the treatment of Parkinson's disease.
de Freitas Silva M; Juliet Cristancho Ortiz C; Ferreira Coelho L; Pruccoli L; Pagliarani B; Pisani L; Catto M; Poli G; Tuccinardi T; Cardoso Vilela F; Giusti-Paiva A; Amaral Alves M; Ribeiro de Souza HM; Tarozzi A; Silva Gontijo V; Viegas C
Bioorg Chem; 2024 Jun; 150():107587. PubMed ID: 38941700
[TBL] [Abstract][Full Text] [Related]
2. A Comprehensive Study to Determine the Residual Elimination Pattern of Major Metabolites of Amoxicillin-Sulbactam Hybrid Molecules in Rats by UPLC-MS/MS.
Zhao F; Sun X; Li J; Du J; Wu Z; Liu S; Chen L; Fang B
Molecules; 2024 May; 29(10):. PubMed ID: 38792031
[TBL] [Abstract][Full Text] [Related]
3. A Comprehensive Study to Identify Major Metabolites of an Amoxicillin-Sulbactam Hybrid Molecule in Rats and Its Metabolic Pathway Using UPLC-Q-TOF-MS/MS.
Zhao FK; Shi RB; Sun YB; Yang SY; Chen LZ; Fang BH
Metabolites; 2022 Jul; 12(7):. PubMed ID: 35888786
[TBL] [Abstract][Full Text] [Related]
4. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease.
Li Q; He S; Chen Y; Feng F; Qu W; Sun H
Eur J Med Chem; 2018 Oct; 158():463-477. PubMed ID: 30243151
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and biological evaluation of new thalidomide-donepezil hybrids as neuroprotective agents targeting cholinesterases and neuroinflammation.
Cristancho Ortiz CJ; de Freitas Silva M; Pruccoli L; Fonseca Nadur N; de Azevedo LL; Kümmerle AE; Guedes IA; Dardenne LE; Leomil Coelho LF; Guimarães MJ; da Silva FMR; Castro N; Gontijo VS; Rojas VCT; de Oliveira MK; Vilela FC; Giusti-Paiva A; Barbosa G; Lima LM; Pinheiro GB; Veras LG; Mortari MR; Tarozzi A; Viegas C
RSC Med Chem; 2022 May; 13(5):568-584. PubMed ID: 35694691
[TBL] [Abstract][Full Text] [Related]
6. Cinnamoyl-N-Acylhydrazone-Donepezil Hybrids: Synthesis and Evaluation of Novel Multifunctional Ligands Against Neurodegenerative Diseases.
Ortiz CJC; Damasio CM; Pruccoli L; Nadur NF; de Azevedo LL; Guedes IA; Dardenne LE; Kümmerle AE; Tarozzi A; Viegas C
Neurochem Res; 2020 Dec; 45(12):3003-3020. PubMed ID: 33079324
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and pharmacological evaluation of N-benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates.
Dias Viegas FP; de Freitas Silva M; Divino da Rocha M; Castelli MR; Riquiel MM; Machado RP; Vaz SM; Simões de Lima LM; Mancini KC; Marques de Oliveira PC; Morais ÉP; Gontijo VS; da Silva FMR; D'Alincourt da Fonseca Peçanha D; Castro NG; Neves GA; Giusti-Paiva A; Vilela FC; Orlandi L; Camps I; Veloso MP; Leomil Coelho LF; Ionta M; Ferreira-Silva GÁ; Pereira RM; Dardenne LE; Guedes IA; de Oliveira Carneiro Junior W; Quaglio Bellozi PM; Pinheiro de Oliveira AC; Ferreira FF; Pruccoli L; Tarozzi A; Viegas C
Eur J Med Chem; 2018 Mar; 147():48-65. PubMed ID: 29421570
[TBL] [Abstract][Full Text] [Related]
8. The development of 2-acetylphenol-donepezil hybrids as multifunctional agents for the treatment of Alzheimer's disease.
Zhu G; Wang K; Shi J; Zhang P; Yang D; Fan X; Zhang Z; Liu W; Sang Z
Bioorg Med Chem Lett; 2019 Oct; 29(19):126625. PubMed ID: 31444085
[TBL] [Abstract][Full Text] [Related]
9. Novel donepezil-chalcone-rivastigmine hybrids as potential multifunctional anti-Alzheimer's agents: Design, synthesis, in vitro biological evaluation, in vivo and in silico studies.
Sang Z; Bai P; Ban Y; Wang K; Wu A; Mi J; Hu J; Xu R; Zhu G; Wang J; Zhang J; Wang C; Tan Z; Tang L
Bioorg Chem; 2022 Oct; 127():106007. PubMed ID: 35849893
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of 4-hydroxy-methylpiperidinyl-N-benzyl-acylarylhydrazone hybrids designed as novel multifunctional drug candidates for Alzheimer's disease.
Macedo Vaz S; de Freitas Silva M; Dos Reis Rosa Franco G; Jorge R Guimarães M; Motta R da Silva F; Gonçalves Castro N; Alvim Guedes I; Dardenne LE; Amaral Alves M; Garrett da Costa R; Beserra Pinheiro G; Germino Veras L; Renata Mortari M; Pruccoli L; Tarozzi A; Viegas C
Bioorg Med Chem; 2022 Oct; 71():116952. PubMed ID: 35930852
[TBL] [Abstract][Full Text] [Related]
11. Regioselective microwave synthesis and derivatization of 1,5-diaryl-3-amino-1,2,4-triazoles and a study of their cholinesterase inhibition properties.
Santos SN; Alves de Souza G; Pereira TM; Franco DP; de Nigris Del Cistia C; Sant'Anna CMR; Lacerda RB; Kümmerle AE
RSC Adv; 2019 Jun; 9(35):20356-20369. PubMed ID: 35514684
[TBL] [Abstract][Full Text] [Related]
12. Inflammation in multiple sclerosis.
Haase S; Linker RA
Ther Adv Neurol Disord; 2021; 14():17562864211007687. PubMed ID: 33948118
[TBL] [Abstract][Full Text] [Related]
13. Cholinergic Modulation of the Immune System in Neuroinflammatory Diseases.
Reale M; Costantini E
Diseases; 2021 Apr; 9(2):. PubMed ID: 33921376
[TBL] [Abstract][Full Text] [Related]
14. Disease-modifying treatment with I
Vasilopoulou F; Rodríguez-Arévalo S; Bagán A; Escolano C; Griñán-Ferré C; Pallàs M
Br J Pharmacol; 2021 Aug; 178(15):3017-3033. PubMed ID: 33817786
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
